People often ask me what’s happening in the energy space—especially now, when the economy feels like it’s shifting beneath our feet. My answer is always the same: this is just a phase. Markets evolve, ...

One challenge for innovators at MSK and elsewhere is that technology development is costly and funding options are limited—especially once the potential for federal grant funding has been exhausted.

Chiltern Vital Group (CVG) and Cambridge Atomworks are pleased to announce the signing of a letter of intent to facilitate research and development into Cambridge Atomworks’ ODIN nuclear micro-reactor ...